Lamisopt

Lamisopt

dorzolamide

Manufacturer:

Rafarm

Distributor:

Maxxcare

Marketer:

Mega Lifesciences
Concise Prescribing Info
Contents
Dorzolamide
Indications/Uses
To lower raised pressure in the eye & treat glaucoma as monotherapy or in addition to other medicines which lower pressure in the eye eg, β-blockers.
Dosage/Direction for Use
Monotherapy 1 drop in the affected eye(s) in the morning, afternoon & evening. Use w/ β-blocker eye drop 1 drop in the affected eye(s) in the morning & evening at least 10 min apart.
Contraindications
Allergy. Severe kidney impairment, or prior history of kidney stones.
Special Precautions
Discontinue if an allergic reaction is suspected. Patients with history of eye problems & surgeries, & any medication allergies. Patient may develop eye irritation or problems eg, redness of the eye or swelling of the eyelids. May discolour soft contact lenses. Remove contact lenses prior to application & wait at least 15 min before reinsertion. May affect ability to drive or operate machinery. Liver impairment. Not for use during pregnancy. Not recommended in lactation.
Adverse Reactions
Burning & stinging of the eyes. Sore eye & blurred vision, discharge w/ itching of the eyes, irritation/inflammation of the eyelid, headache, nausea, bitter taste, & fatigue.
Drug Interactions
Carbonic anhydrase inhibitor eg, acetazolamide; sulfa drugs.
MIMS Class
Antiglaucoma Preparations
ATC Classification
S01EC03 - dorzolamide ; Belongs to the class of carbonic anhydrase inhibitors. Used in the treatment of glaucoma.
Presentation/Packing
Form
Lamisopt eye drops 20 mg/mL
Packing/Price
5 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in